Rome Foundation

Rome Foundation
Name	Rome Foundation
Formation	2000
Type	Nonprofit organization
Headquarters	Philadelphia, Pennsylvania
Leader title	President
Leader name	Douglas Drossman
Focus	Functional gastrointestinal disorders, irritable bowel syndrome, gastroparesis

Rome Foundation

The Rome Foundation is an international nonprofit organization dedicated to the study, classification, and treatment of functional gastrointestinal disorders including irritable bowel syndrome, functional dyspepsia, and functional constipation. Founded at the turn of the 21st century, it develops consensus criteria, supports clinical research, provides education, and engages with professional societies, academic centers, patient groups, and regulatory agencies. The Foundation is widely associated with the development of the Rome diagnostic criteria series and collaborates across gastroenterology, neurology, psychology, and public health communities.

History

The Foundation emerged from collaborative efforts among clinicians and researchers at institutions such as the Mayo Clinic, Massachusetts General Hospital, University of California, San Francisco, Johns Hopkins Hospital, and the National Institutes of Health to address inconsistencies in diagnosing functional gastrointestinal disorders. Key milestones include publication of the original consensus statements in the early 2000s, subsequent revisions tied to international meetings in cities like Rome, Tokyo, Paris, and Madrid, and the release of major updates that paralleled initiatives by the World Health Organization, the American Gastroenterological Association, the American College of Gastroenterology, and the European Society for Neurogastroenterology and Motility. Influential contributors have included leaders affiliated with Duke University, University College London, Karolinska Institutet, McMaster University, University of Sydney, and King's College London. Over time the Foundation forged links with patient advocacy groups such as the American Gastrointestinal Association and networks including the Inflammatory Bowel Disease Registry and several clinical trial consortia.

Mission and Activities

The Foundation’s mission aligns with organizations such as the Food and Drug Administration, the European Medicines Agency, and the World Gastroenterology Organisation in standardizing endpoints for clinical trials, refining patient-reported outcome measures, and guiding regulatory science for therapeutics. Its activities encompass convening expert panels modeled on processes used by the Institute of Medicine and the Cochrane Collaboration, hosting symposia at meetings like the Digestive Disease Week and the United European Gastroenterology Week, and issuing white papers that influence practice guidelines from the American College of Physicians and specialty groups worldwide. The Foundation collaborates with academic publishers including The Lancet, Gastroenterology (journal), Gut (journal), Clinical Gastroenterology and Hepatology, and Neurogastroenterology & Motility to disseminate consensus documents.

Research and Publications

The Foundation oversees multicenter studies and registries linked to centers such as Cleveland Clinic, Stanford University School of Medicine, Columbia University Vagelos College of Physicians and Surgeons, Yale School of Medicine, and Harvard Medical School. It has promulgated successive diagnostic criteria versions adopted in systematic reviews by the Cochrane Library and cited in meta-analyses from teams at Johns Hopkins Bloomberg School of Public Health, Imperial College London, and McGill University. Key publications have appeared in journals including Nature Reviews Gastroenterology & Hepatology, BMJ, Annals of Internal Medicine, and specialty literature produced in collaboration with societies such as the American Psychiatric Association and the International Association for the Study of Pain. The Foundation’s tools—symptom questionnaires and classification algorithms—are used in trials conducted by pharmaceutical companies and academic groups, often alongside biomarkers studied at centers like Scripps Research, Broad Institute, and Karolinska University Hospital.

Education and Training

Educational initiatives mirror programs at the European School of Oncology and professional development tracks at the American Board of Internal Medicine and include workshops, online modules, and certification courses delivered with partners such as Barnes-Jewish Hospital, Vanderbilt University Medical Center, University of Michigan Health System, Mayo Clinic College of Medicine and Science, and continuing medical education providers like Accreditation Council for Continuing Medical Education. Training targets multidisciplinary teams drawn from departments at Rutgers University, University of Toronto, Monash University, and Seoul National University Hospital, integrating approaches from behavioral medicine groups affiliated with University of Pennsylvania, University of California, Los Angeles, and Northwestern University.

Organizational Structure

The Foundation is governed by a board of directors and advisory committees comprising clinicians, researchers, and patient representatives from institutions including Dartmouth College, University of Edinburgh, Tel Aviv University, University of Amsterdam, and Peking University. Scientific committees oversee guideline development, while operational units handle communications, finance, and conference planning in coordination with legal and ethical review from partners such as King's College Hospital and ethics boards affiliated with Columbia University. Leadership roles have been held by scholars connected to University of North Carolina at Chapel Hill, University of Pennsylvania Health System, and University of Chicago Medicine.

Funding and Partnerships

Funding sources include philanthropic grants, conference revenues, royalties from educational products, and research contracts with public funders like the National Institute of Diabetes and Digestive and Kidney Diseases and private foundations such as the Gordon and Betty Moore Foundation and the Bill & Melinda Gates Foundation where mission alignment exists. Collaborative partnerships extend to pharmaceutical firms, diagnostics companies, and nonprofits including the Crohn's & Colitis Foundation, European Crohn's and Colitis Organisation, and patient advocacy groups from regions represented by World Health Organization collaborations. The Foundation maintains transparency policies akin to those recommended by the International Committee of Medical Journal Editors and financial oversight practices comparable to standards used by United Way Worldwide and international grant-making bodies.

Category:Medical organizations